AXSM
AXSM
NASDAQ · Pharmaceuticals

Axsome Therapeutics Inc

$247.85
-2.65 (-1.06%)
As of Jun 22, 9:45 PM ET ·
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Buy 25 93%
Hold 2 7%
Sell 0 0%
Price Target
Analyst Price Target -73.4% upside
Low Target $47.60
Average Target $66.03
High Target $88.20
Current Price $247.85
Current
$247.85
Target
$66.03
$47.60 $66.03 avg $88.20
Scenario Analysis
Bear Case
$47.60
-80.8%
Low target
Base Case
$66.03
-73.4%
Avg target
Bull Case
$88.20
+-64.4%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$260.19
-4.7% from high
52-Week Low
$96.09
+157.9% from low
50-Day SMA
$171.07
+44.9% vs SMA
200-Day SMA
$131.37
+88.7% vs SMA
RSI (14)
51.8
Neutral
Target vs 52W High
$66.03
-74.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -32.3%